Dr-Kesava-Reddy

KESAVA REDDY: ASSOCIATE DIRECTOR OF MEDICAL RESEARCH

Dr. Kesava Reddy works in association with Dr. Mark D’Andrea at University Cancer Centers and conducts clinical research, creates institutional review board protocols, and provides data analysis and interpretation of complex clinical data.

He was an Assistant Professor at the University of Kansas Medical Center in Kansas City, KS, for 13 years. He received his Ph.D. in Biochemistry from the University of Madras, India, and his Masters in Health Services Administration from the University of Kansas.

­­­­­­­­­­­­­­­­ PUBLICATIONS

Long-term outcomes of ventriculoperitoneal shunt surgery in patients with hydrocephalus
2012 Feb
Ventriculoperitoneal shunt surgery outcome in adult transition patients with pediatric-onset hydrocephalus
2012 Feb
Ventriculoperitoneal shunt surgery and the incidence of shunt revision in adult patients with hemorrhage-related hydrocephalus.
2012 Nov
Ventriculoperitoneal shunt surgery and the risk of shunt infection in patients with hydrocephalus: long-term single institution experience
2012 Jul
Ventriculoperitoneal shunt complications in hydrocephalus patients with intracranial tumors: an analysis of relevant risk factors
2011 Jun
Fatal consequences of a simple mistake: how can a patient be saved from inadvertent intrathecal vincristine?
2011 Jan
Management of adult hydrocephalus with ventriculoperitoneal shunts: long-term single-institution experience.
2011 Oct
Obstructive hydrocephalus in adult patients: the Louisiana State University Health Sciences Center-Shreveport experience with ventriculoperitoneal shunts
2011 Jul-Aug
Clinicalutility of microarray-derived genetic signatures in predicting outcomes in prostate cancer.
2006 Dec
Current data with mammalian target of rapamycin inhibitors in advanced-stage renal cell carcinoma.
2006 Sep
Sorafenib: recent update on activity as a single agent and in combination with interferon-alpha2 in patients with advanced-stage renal cell carcinoma.
2006 Mar
Prognostic significance of increasing lymph node count in stage III colorectal cancer.
2006 Mar
The role of immunotherapy in the treatment of colorectal cancer.
2006 Jan
Clinical utility of novel agents in the treatment of central venous catheter occlusion.
2006 Apr
Optimizing the management of treatment-related peripheral neuropathy in patients with multiple myeloma.
2006 Oct
Novel approaches in the management of myeloma-related skeletal complications.
2006 Oct
The Role of Plerixafor (AMD3100) in Mobilizing Hematopoietic Progenitor Cells in Patients with Hematologic Malignancies.
2006 Jan
Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapy-induced emesis.
2006 Apr
Denosumab (AMG 162), a Fully Human Monoclonal Antibody Against RANK Ligand Activity.
2005 Oct
Role of prophylactic quinolones in reducing febrile neutropenia in patients undergoing myelosuppressive chemotherapy.
2005 Jan
Palifermin is efficacious in reducing oral mucositis induced by intensive cancer therapy.
2005 Jan
Impact of erythropoietic agents on survival of anemic patients with cancer.
2005 Apr
Pegfilgrastim: recent advances in the prophylaxis of chemotherapy-induced neutropenia.
2005 Apr
Role of epidermal growth factor receptor mutations in predicting sensitivity or resistance to targeted agents in non-small-cell lung cancer.
2005 May
Noninvasive visualization of apoptosis using radiolabeled annexin v could predict response to chemotherapy.
2005 Nov
Relevance of epidermal growth factor receptor genomic gain in predicting clinical response to kinase inhibitors in non-small-cell lung cancer.
2005 Nov
Paclitaxel poliglumex/carboplatin is similar to paclitaxel/carboplatin as first-line treatment in elderly patients with advanced non-small-cell lung cancer and a poor performance status.
2005 Jul
Capecitabine/Oxaliplatin combinations in advanced colorectal cancer: summary of recent randomized studies.
2005 Nov
Preoperative chemoradiation therapy shows improved clinical benefit in patients with rectal cancer.
2005 Sep
Recent data with oxaliplatin-containing regimens in the adjuvant treatment of colorectal cancer.
2005 Jul
Evolution of FOLFOX regimens in the treatment of advanced colorectal cancer.
2005 Jan
Intergroup trial fails to demonstrate a benefit with the addition of irinotecan to bolus 5-fluorouracil/leucovorin in stage III colon cancer.
2004 Nov
Efficacy of adjuvant capecitabine compared with bolus 5-fluorouracil/leucovorin regimen in dukes C colon cancer: results from the X-ACT trial.
2004 Jul
New developments with bortezomib in treating multiple myeloma.
2004 Mar
Abarelix (Plenaxis): a gonadotropin-releasing hormone antagonist for medical castration in patients with advanced prostate cancer.
2004 Mar
Finasteride, a selective 5-alpha-reductase inhibitor, in the prevention and treatment of human prostate cancer.
2004 Mar
Kyphoplasty in the management of cancer-associated vertebral compression fractures.
2004 Oct
Current strategies to minimize treatment-associated hot flashes in patients with breast cancer.
2004 Jul
Incidence of thromboembolism and role of low molecular weight heparin in prolonging survival in patients with advanced malignancies.
2004 Oct
AGE-related cross-linking of collagen is associated with aortic wall matrix stiffness in the pathogenesis of drug-induced diabetes in rats.
2004 Sep
Photobiological basis and clinical role of low-intensity lasers in biology and medicine.
2004 Apr
Comparison of the photostimulatory effects of visible He-Ne and infrared Ga-As lasers on healing impaired diabetic rat wounds.
2003
Glucose-mediated in vitro glycation modulates biomechanical integrity of the soft tissues but not hard tissues.
2003 Jul
Glycation-induced matrix stability in the rabbit achilles tendon.
2002 Mar
Photoactivated coumaryl-diazopyruvate fluorescent label for amine functional groups of tissues containing type-I collagen.
2002 Nov
Laser photostimulation accelerates wound healing in diabetic rats.
2001 May-Jun
The biomechanical integrity of bone in experimental diabetes.
2001 Oct
Effect of mulberry (Morus indica L.) therapy on plasma and erythrocyte membrane lipids in patients with type 2 diabetes.
2001 Dec
Matrix remodeling in healing rabbit Achilles tendon.
1999 Nov-Dec
Laser photostimulation of collagen production in healing rabbit Achilles tendons.
1998
Biochemistry and biomechanics of healing tendon: Part I. Effects of rigid plaster casts and functional casts.
1998 Jun
Biochemistry and biomechanics of healing tendon: Part II. Effects of combined laser therapy and electrical stimulation.
1998 Jun
Combined ultrasound, electrical stimulation, and laser promote collagen synthesis with moderate changes in tendon biomechanics.
A simplified method for the analysis of hydroxyproline in biological tissues.
1996 Jun
Structure and composition of type IV collagen of bovine aorta.
1993 Jul
Reductive cleavage of the disulfide bonds of the collagen IV noncollagenous domain in aqueous sodium dodecyl sulfate: absence of intermolecular nondisulfide cross-links.
1993 Jan
Serum form of the erythropoietin receptor identified by a sequence-specific peptide antibody.
1993 Oct
Neoplastic association of enhanced type V collagen production in rat fibrosarcoma.
1993 Mar
Purification and characterization of collagens from rat fibrosarcoma induced by 3-methylcholanthrene.
1993 Apr 21
Purification and characterization of recombinant porcine prorelaxin expressed in Escherichia coli.
1992 May
Purification and characterization of collagenolytic property of renal cathepsin L from arthritic rat.
1992 Sep
Metabolic studies on connective tissue collagens in bone and tendon of adjuvant arthritic rat.
1992 Apr
Connective tissue metabolism in bone and cartilage of adjuvant arthritic rat.
1991
Metabolism of glycosaminoglycans in tissues of adjuvant arthritic rat.
1991 Aug
Molecular characteristics of soluble arthritic collagens.
1990 Feb
Metabolism of collagen in bone of adjuvant induced arthritic rat.
1989
Studies on the metabolism of glycosaminoglycans under the influence of new herbal anti-inflammatory agents.
1989
Studies on carbohydrate moieties of glycoproteins in established adjuvant induced arthritis.
1988 Aug
Effect of a new non-steroidal anti-inflammatory agent on lysosomal stability in adjuvant induced arthritis.
1987 Jul-Aug
Urinary excretion of connective tissue metabolites under the influence of a new non-steroidal anti-inflammatory agent in adjuvant induced arthritis.
1987 Oct

EASY ONLINE APPOINTMENTS

Schedule an Appointment